Arthritis drug Actemra was no better than a placebo in improving Covid-19 patients’ clinical status, including the need for ventilators or intensive care
Roche Holding AG said its anti-inflammatory drug Actemra failed to help Covid-19 patients in a late-stage clinical trial, the latest setback for a class of drugs that doctors hope can halt a haywire immune reaction linked to the new coronavirus.
In a study of 452 hospitalized Covid-19 patients, Actemra was no better than a placebo in improving patients’ clinical status, including the need for ventilators or intensive care. There was no difference in the death rate between the treatment and control groups, with 19.7% of Actemra...
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Roche trial of drug to treat COVID-19-related pneumonia failsA late-stage clinical trial of Roche's Actemra/RoActemra drug to treat patients hospitalised with severe COVID-19-related pneumonia failed, the drugmaker said on Wednesday.
Weiterlesen »
Roche trial of drug to treat COVID-19-related pneumonia failsA late-stage clinical trial of Roche's Actemra/RoActemra drug to treat patients hospitalised with severe COVID-19-related pneumonia failed, the drugmaker said on Wednesday.
Weiterlesen »
Amber Gills gets tested for COVID-19 after falling ill following Ibiza tripThe former Love Island champion shut down fans who suggested that she had coronavirus and revealed that she had even had a test that had come back negative
Weiterlesen »
FDA authorizes first COVID-19 test for people without symptomsNew research finds similar levels of the virus in people who test positive with and without symptoms.
Weiterlesen »